How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PS

NASDAQ:PSNL
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PS

Personalis IncNASDAQ PSNL Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is PSNL undervalued compared to its fair value?

The fair value of PSNL stock is hidden USD. Relative to the market price of 3.85 USD Personalis Inc is hidden.

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company is headquar...[More about valuation]

Personalis Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.127 $B

Price:

3.85 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.256

FINANCIALS

Personalis financial for reporting period

Income Statement

0.02 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.019 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.013 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.02 B 100%
0.0055 B 28%
-0.019 B -97%
-0.013 B -66%

Balance Sheet

0.2 B
0.12 B

0.0026 B

Financial Position Analysis

Assets

0.2 B
Current Assets
0.12 B
Total non-current assets
0.075 B

Total current liabilities
0.031 B
Total non-current liabilities
0.043 B

Cash Flow Statement

-0.021 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.02 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Personalis fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-64 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-117 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-41 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is PSNL attractive for investment based on fundamental analysis?

PSNL stock rating is hidden. Personalis is a hidden by Eyestock methodology.

Get PSNL Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-125

Gross Margin:

26

CFO / Debt ratio:

hidden

Current ratio:

4.126

Debt / Equity ratio:

0.012

ROE:

-64

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

PSNL analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for PSNL to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Personalis Inc competitors

TM

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, an...

Discover

DH

DHR

Danaher Corp

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company is headqu...

Discover

LO

LONN.SW

Lonza Group AG

Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt. The company went IPO on 2002-0...

Discover

Personalis Inc dividends

PSNL dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About PSNL stock

About the company Personalis Inc

Market cap $B

0.127

Dividend yield

Shares outstanding

46.7368 B

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company is headquartered in Menlo Park, California and currently employs 395 full-time employees. The company went IPO on 2019-06-20. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other next generation cancer immunotherapies. The NeXT platform is a next generation sequencing and analysis platform. The NeXT platform is designed to provide comprehensive analysis of both a tumor and its immune microenvironment from a single limited tissue or plasma sample. Its products are designed to detect recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Its research-focused products include exome sequencing, transcriptome sequencing, and targeted cancer panels. The Company’s platform analyses elements of the immune cells that have infiltrated a tumor both from the adaptive immune system and the innate immune system.

PSNL profile

  • Ticker

    PSNL

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    20 June 2019

  • Sector

    Healthсare

  • Industry

    Life Sciences Tools & Services

  • Employees

    395

  • City

    Menlo Park

  • Address

    1330 O'brien Drive

  • Cusip

    71535D106